Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

NCT01057212 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Lack of support from pharmaceutical collaborator.

Conditions

Non-squamous Non-small Cell Lung Cancer

Interventions

DRUG: ixabepilone
DRUG: bevacizumab

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]